Covid-19: Pfizer-bioNTech ta ba da sanarwar cewa rigakafinta na da "lafiya" ga masu shekaru 5-11

Shin allurar rigakafin na yara masu shekaru 5-11 daga Covid-19 na zuwa nan ba da jimawa ba? A kowane hali, wannan yuwuwar ya ɗauki babban mataki na gaba, tare da sanarwar Pfizer-bioNTech. Yanzu haka dai kungiyar ta buga sakamakon wani bincike da ke da kwarin gwiwar yi wa kananan yara allurar rigakafi, tun daga shekaru 5 da haihuwa. A cikin sanarwar da suka fitar, ƙwararrun masu yin magunguna sun ba da sanarwar cewa ana ɗaukar allurar a matsayin "lafiya" kuma 'yan shekaru 5 zuwa 11 sun amince da su sosai. Har ila yau, binciken ya jaddada cewa adadin da ya dace da yanayin halittar wannan rukunin shekarun ya ba da damar samun amsawar rigakafi wanda ya cancanta a matsayin "mai ƙarfi", da "kwatankwacin" sakamakon da aka lura a cikin 16-25 masu shekaru. An gudanar da wannan binciken yara 4 tsakanin watanni 500 zuwa 6 a Amurka, Finland, Poland da Spain. Za a mika shi ga hukumomin kiwon lafiya “da wuri-wuri,” a cewar Pfizer-bioNtech.

Gabatarwa ga yara masu shekaru 2-5

Pfizer-bioNTech baya niyyar tsayawa a can. Lallai yakamata kungiyar ta buga “Daga kwata na hudu »Sakamako na ƙungiyar masu shekaru 2-5, da kuma watanni 6-2, wanda ya samu allurai biyu na microgram 3. A gefen mai fafatawa a gasar Moderna, a halin yanzu ana ci gaba da bincike kan yara 'yan kasa da shekaru 12.

Covid-19: sabuntawa kan rigakafin yara da matasa

Kamfen ɗin rigakafin Covid-19 yana faɗaɗa. Kamar yadda muka sani, matasa masu shekaru 12 zuwa 17 sun riga sun amfana da maganin. Menene muka sani game da amincin rigakafin ga ƙarami? Ina bincike da shawarwari? Ina bincike da shawarwari? Muna daukar lissafi.

Alurar riga kafi na yara masu shekaru 12-17 akan Covid-19: anan ne izinin iyaye don saukewa

An fara allurar rigakafin matasa masu shekaru 12 zuwa 17 a kan Covid-19 a ranar Talata, 15 ga Yuni a Faransa. Ana buƙatar izini na duka iyaye, da kasancewar aƙalla iyaye ɗaya. Ana buƙatar izinin baka daga matashi. 

Wane maganin alurar riga kafi ga matasa?

Tun daga Yuni 15, 2021, matasa masu shekaru 12 zuwa 17 za a iya yi musu allurar rigakafin Covid-19. Alurar riga kafi da aka ba da izini zuwa yau a cikin wannan rukunin shekaru, Alurar riga kafi daga Pfizer / BioNTech. Alurar rigakafin Moderna tana jiran izini daga Hukumar Kula da Magunguna ta Turai.

Cikakkun bayanai daga ma'aikatar lafiya: « Ana ba da damar yin rigakafin ga duk yara masu shekaru 12 zuwa 17 daga ranar 15 ga Yuni, 2021, ban da samari waɗanda suka kamu da cutar kumburin ƙwayar cuta ta yara (PIMS) bayan kamuwa da cuta. ta SARS-CoV-2, wanda ba a ba da shawarar rigakafin ba ".

Izinin iyaye yana da mahimmanci

A shafinta na yanar gizo, ma'aikatar lafiya da hadin kai ta nuna cewa a izini daga iyaye biyu wajibi ne. Kasancewaraƙalla iyaye ɗaya yana da mahimmanci yayin allurar rigakafi.

Sai dai ma'aikatar lafiya ta bayyana hakan "A gaban iyaye ɗaya kawai a lokacin rigakafin, na ƙarshe ya ɗauki nauyin girmamawar da iyaye tare da ikon iyaye suka ba shi izini. "

Amma ga matashi, dole ne ya ba da nasa yarda ta baka, "Yanci da wayewa", ya ƙayyade ma'aikatar.

Zazzage izinin iyaye don rigakafin samari daga shekaru 12 zuwa 17

Za ka iya saukeizinin iyaye a nan. Za ku buƙaci buga shi, cika shi kuma ku kawo shi ga alƙawarin shawarwari.

COVID-19: allurar rigakafi na samari, yanke shawara da sauri bisa ga Kwamitin Da'a

A watan Afrilun da ya gabata, Ma'aikatar Lafiya ta yi fatan samun ra'ayin kwamitin da'a game da batun bude allurar rigakafin COVID-19 zuwa 12-18 daga ranar 15 ga Yuni. da sauri: yana ambaton sakamakon da ke iyakance daga ra'ayi na kiwon lafiya, amma mahimmanci daga ra'ayi na ɗabi'a.

Kasa da shekara guda bayan barkewar cutar ta COVID-19, tallan rigakafin rigakafin ya canza wasan ta hanyar ƙara matakan shinge zuwa babban ƙarin kayan aikin rigakafi. Wasu ƙasashe ma sun ba da izinin yin rigakafi ga masu kasa da shekaru 18, kamar Kanada, Amurka da Italiya. Faransa ma na kan wannan hanya tun da matasa masu shekaru 12 zuwa 18 za su iya yin allurar daga ranar 15 ga watan Yuni, in ji Emmanuel Macron a ziyarar da ya kai Saint-Cirq-Lapopie. Idan an yi wannan rigakafin ne bisa son rai. tare da yarjejeniyar iyaye, koren haske an ba shi da wuri, cikin gaggawa? Waɗannan su ne abubuwan da kwamitin da'a na ƙasa (CCNE) ya yi.

Kungiyar ta yi tambaya game da saurin wannan shawarar, a cikin yanayin raguwar annobar. “Akwai cikakkiyar gaggawa don fara alurar riga kafi yanzu, lokacin da alamomi da yawa suna kore kuma farkon shekarar makaranta na Satumba na iya nuna farkon yakin? Ya rubuta a cikin sanarwar manema labarai. A cikin ra'ayin sa, CCNE ta tuna cewa bisa ga bayanan kimiyya, manyan nau'ikan kamuwa da cuta na COVID-19 ba su da yawa ga masu kasa da shekaru 18 : amfanin mutum ɗaya da aka samu daga allurar rigakafi saboda haka yana iyakance ga lafiyar "jiki" na matasa. Amma makasudin wannan ma'auni kuma shi ne don samun rigakafin gama-gari a tsakanin jama'a.

Wani ma'auni mai amfani don rigakafin gama kai?

A wannan yanki, masana sun yarda cewa "da wuya a iya cimma wannan manufa ta hanyar allurar rigakafin manya kawai." Dalilin yana da sauƙi: ƙididdiga na nazari fiye da gama kai rigakafi za a kai shi ne kawai idan kashi 85% na dukan jama'a an yi musu rigakafi, ko dai ta hanyar rigakafin ko kuma ta kamuwa da cuta a baya. Ƙari ga wannan shine gaskiyar cewa ikon yara na kamuwa da cutar da yada kwayar cutar ya wanzu kuma yana karuwa da shekaru, har ma yana nuna kansa a kusa da matasa ga abin da ake gani a cikin matasa. Ga yara masu shekaru 12-18, ana iya yin allurar rigakafin kawai tare da alurar rigakafin Pfizer, a halin yanzu. kawai yarda a Turai ga wannan yawan jama'a.

Kwamitin yana da kwarin gwiwa game da bayanan aminci na rigakafin, wanda tare da hangen nesa na wasu watanni, “zai yiwu alurar riga kafi ga masu shekaru 12-17. "Kuma wannan, ko da" ƙasa da wannan shekarun, babu bayanai da ke samuwa. "Rashin sonsa shine mafi dabi'ar dabi'a:" Shin yana da kyau a sa yara ƙanana su ɗauki alhakin, dangane da fa'idar gama kai, don ƙin yin rigakafi (ko wahalar samunsa) don wani ɓangare na rigakafin? yawan manya? Shin babu wani abin ƙarfafawa don yin rigakafi don samun 'yanci da komawa rayuwa ta al'ada? Ya tambayi kansa. Akwai kuma tambaya ta " abin kunya ga matasa wanda ba zai so ya yi amfani da shi ba. "

A ƙarshe, wani haɗarin da aka ambata shine na “karya kwarin gwiwarsu idan an lalata rayuwarsu ta yau da kullun zuwan sababbin bambance-bambancen karatu », Yayin da kasancewar bambance-bambancen Indiya (Delta) a Faransa ke samun ƙasa. Duk da yake Kwamitin bai amince da wannan shawarar ba, kuma ya dage kan mutunta yardar matasa, ya ba da shawarar a sanya wasu matakan daidai gwargwado. Na farko shine bibiyar lura da magunguna kan matsakaita da dogon lokaci a samari da aka yiwa rigakafin. A cewarsa, ya zama dole kuma a inganta sanannen dabarun “Gwaji, gano, ware” a cikin yara ƙanana ta yadda "ana iya ɗaukarsa azaman madadin dabarun rigakafi." », Ya ƙarasa.

Alurar riga kafi na matasa daga Covid-19: amsoshin tambayoyinmu

Emmanuel Macron ya ba da sanarwar a ranar 2 ga Yuni cewa za a bude allurar rigakafin cutar sankara ta Sars-CoV-2 ga matasa masu shekaru 12 zuwa 17. Sabili da haka, tambayoyi da yawa sun taso, musamman game da nau'in maganin alurar riga kafi, yiwuwar sakamako masu illa, amma har da izinin iyaye ko lokaci. Nuna

Ana iya yin allurar rigakafin Covid-19 daga Yuni 15, 2021

A wani jawabi mai kwanan ranar 2 ga watan Yuni, shugaban kasar ya sanar bude allurar rigakafin ga yara masu shekaru 12-18 daga 15 ga Yuni, " a ƙarƙashin yanayin ƙungiya, yanayin tsafta, izinin iyaye da kyakkyawan bayani ga iyalai, ɗabi'a, wanda hukumomin kiwon lafiya da hukumomin da suka cancanta za a ayyana su a cikin kwanaki masu zuwa. »

A maimakon haka yana goyon bayan allurar mataki-mataki

Ya zama cewa shugaban ya yi tsammanin ra'ayin Babban Hukumar Lafiya, wanda aka buga a ranar Alhamis, 3 ga Yuni da safe.

Idan ta yarda cewa lallai akwai"kai tsaye amfanin mutum“Kuma kaikaice, da kuma fa’ida ta gama-gari ga allurar rigakafin samari, shi duk da haka yana ba da shawarar ci gaba mataki-mataki, ta hanyar buɗe shi a matsayin fifiko ga yara masu shekaru 12-15 tare da yanayin haɗin gwiwa ko na cikin rakiyar wani mai rigakafi ko mai rauni. Na biyu, ta ba da shawarar mika shi ga duk samari, " da zaran yaƙin neman zaɓe ga manyan mutane ya ci gaba sosai.

Babu shakka, shugaban na Jamhuriyar ya fi son kada ya yi tagulla, kuma ya sanar da cewa allurar rigakafin ga yara masu shekaru 12-18 za su kasance ga kowa, ba tare da sharadi ba.

Pfizer, Moderna, J & J: menene maganin alurar riga kafi da aka baiwa matasa?

A ranar Juma'a, 28 ga Mayu, Hukumar Kula da Magunguna ta Turai (EMA) ta ba da koren haske don gudanar da allurar rigakafin Pfizer / BioNTech ga matasa masu shekaru 12 zuwa 15. Ga matasa masu shekaru 16 zuwa sama, an ba da izinin wannan rigakafin mRNA (a ƙarƙashin yanayi) tun Disamba 2020.

A wannan mataki, don haka maganin Pfizer / BioNTech ne za a yi ga matasa tun daga ranar 15 ga Yuni. Amma ba a cire shi ba cewa maganin na Moderna yana samun izini daga Hukumar Kula da Magunguna ta Turai.

Alurar rigakafin Covid-XNUMX ga matasa: menene fa'idodin? 

An gudanar da gwajin asibiti na Pfizer / BioNTech akan matasa 2 waɗanda ba su taɓa yin kwangilar Covid-000 ba. Daga cikin mahalarta 19 da suka karɓi maganin, babu wanda ya kamu da cutar daga baya, yayin da 1 daga cikin matasa 005 da suka karɓi placebo suka gwada tabbatacce bayan binciken. ” Wanda ke nufin cewa, a cikin wannan binciken, maganin ya yi tasiri 100%. Ƙaddamar da Hukumar Kula da Magunguna ta Turai. Koyaya, samfurin ya kasance kaɗan.

A nata bangaren, Babban Hukumar Kula da Lafiya ta bayar da rahoton "amsawar barkwanci mai karfi”, (watau rigakafin daidaitawa ta hanyar samar da ƙwayoyin rigakafi) wanda allurai biyu na rigakafin Comirnaty (Pfizer / BioNTech) suka haifar a cikin batutuwa masu shekaru 2 zuwa 12, tare da ko ba tare da tarihin kamuwa da cuta ta SARS-CoV-15 ba. Ta kara da cewa "Ingancin 100% na allurar rigakafi akan cututtukan Covid-19 na alamomin da PCR ya tabbatar daga rana ta 7 bayan ƙarshen rigakafin.".

Alurar rigakafin Covid: Moderna yana da 96% tasiri a cikin masu shekaru 12-17, binciken ya gano

Sakamakon farko na gwaji na asibiti da aka gudanar musamman a cikin yawan matasa ya nuna cewa rigakafin COVID-19 na Moderna yana da tasiri 96% a cikin masu shekaru 12-17. Kamfanin harhada magunguna na fatan samun izini a hukumance nan ba da jimawa ba, kamar yadda Pfizer ke yi.

Pfizer ba shine kawai kamfani wanda allurar rigakafin Covid-19 za a iya amfani da a cikin mafi ƙanƙanta. Moderna ta ba da sanarwar cewa maganin ta na COVID-19, wanda kuma ya dogara da manzon RNA, yana da tasiri 96% a cikin matasa masu shekaru 12 zuwa 17, bisa ga sakamakon gwajin asibiti da ake kira "TeenCOVE". A lokacin wannan daya, kashi biyu bisa uku na mahalarta 3 a Amurka sun karbi maganin, kuma kashi daya bisa uku na placebo. “Binciken ya nuna ingancin maganin rigakafi na 96%, gabaɗaya an jure shi da kyau ba tare da wata matsala ta tsaro da aka gano ba har zuwa yau. Ta ce. Don waɗannan sakamako na tsaka-tsaki, an bi mahalarta don matsakaita na kwanaki 35 bayan allura ta biyu.

Kamfanin harhada magunguna ya fayyace cewa duk illar da ake samu " m ko matsakaici ", yawancin lokaci zafi a wurin allurar. Bayan allura ta biyu, illolin sun haɗa da” ciwon kai, gajiya, myalgia da sanyi , Kamar waɗanda aka gani a cikin manya waɗanda suka karɓi maganin. Dangane da waɗannan sakamakon, Moderna ya nuna cewa a halin yanzu " a cikin tattaunawa da masu gudanarwa game da yuwuwar yin gyare-gyare ga kundin tsarin sa Don ba da izinin rigakafin ga wannan rukunin shekaru. Maganin rigakafin mRNA-1273 a halin yanzu an ba da takaddun shaida ga mutane masu shekaru 18 zuwa sama a cikin ƙasashen da aka riga aka amince da su.

Pfizer da Moderna a cikin tseren yin rigakafin yara

Sanarwar sanarwar ta ta bayyana, duk da haka, ” cewa tunda adadin COVID-19 ya ragu sosai a samari, Ma'anar shari'ar ba ta da tsauri fiye da na COVE (nazari a cikin manya), wanda ke haifar da ingancin maganin alurar riga kafi daga cututtuka mafi girma. Sanarwar ta zo ne a daidai lokacin da Hukumar Kula da Abinci da Magunguna za ta sanar da ko za ta ba da izinin amfani da gaggawa na rigakafin Pfizer-BioNTech ga matasa masu shekaru 12 zuwa 15, yayin da Kanada ta zama ƙasa ta farko da ta ba da izinin wannan rukunin masu shekaru. . 

Wannan kuma shine yanayin Moderna wanda, a nata bangaren, ya ƙaddamar a cikin Maris wani binciken asibiti na kashi 2 a ciki yara masu shekaru 6 zuwa shekaru 11 (binciken KidCOVE). Idan alurar riga kafi na samari yana ƙara zama batun tattaunawa, saboda yana wakiltar mataki na gaba a cikin kamfen ɗin rigakafin, wanda ya zama dole a cewar masana kimiyya don sarrafa, cikin dogon lokaci, don ɗaukar cutar ta coronavirus. A lokaci guda kuma, fasahar kere-kere ta Amurka ta bayyana sakamako masu ban sha'awa game da yuwuwar "masu haɓaka", a yiwuwar allura na uku. Zai zama dabarar da aka samar musamman akan bambance-bambancen Brazil da Afirka ta Kudu, ko kuma kashi na uku mai sauƙi na rigakafin farko.

A ina za a yi allurar rigakafin matasa?

Alurar riga kafi ga masu shekaru 12-18 za a yi daga 15 ga Yuni cibiyoyin rigakafi da sauran vaccinodromes aiwatar da shi tun farkon yakin rigakafin. Ministan Lafiya ya tabbatar da hakan a microphone na LCI.

Dangane da jadawalin alurar riga kafi, zai zama fifiko iri ɗaya da na manya. watau makonni 4 zuwa 6 tsakanin allurai biyu, lokacin da za a iya tsawaita shi zuwa makonni 7 ko ma 8 a lokacin bazara., don ba da ƙarin sassauci ga masu yin biki.

Alurar riga kafi ga masu shekaru 12-17: menene illar da za a sa ran?

A wani taron manema labarai, Marco Cavaleri, shugaban dabarun rigakafi a Hukumar Kula da Magunguna ta Turai, ya ce martanin rigakafi na matasa ya kasance. kwatankwacin na matasa manya, ko ma mafi kyau. Ya ba da tabbacin cewa maganin ya kasance "da kyar"Ta hanyar samari, da kuma cewa akwai"babu manyan damuwa”Game da illolin da zai yiwu. Koyaya, ƙwararren ya yarda cewa "Girman samfurin baya bada izinin gano yiwuwar illolin da ba kasafai ba".

Lura cewa an yi allurar rigakafin Pfizer / BioNTech ga matasa na tsawon makonni da yawa tuni a Kanada da Amurka, wanda ke ba da ƙarin bayanan kula da magunguna. Hukumomin Amurka sun ba da sanarwar musamman lokuta da ba kasafai suke faruwa na matsalolin zuciya “mai laushi” ba (myocarditis: kumburi na myocardium, tsokar zuciya). Amma yawan lokuta na myocarditis, wanda zai bayyana maimakon bayan kashi na biyu kuma a maimakon haka a cikin maza, ba zai, a halin yanzu ba, ya wuce yawan abin da ya faru na wannan soyayya a cikin lokutan al'ada a cikin wannan rukunin shekaru.

A nata bangaren, Babban Hukumar Kula da Lafiya ta yi rahoton “ gamsassun bayanan haƙuri An samu a cikin samari 2 masu shekaru 260 zuwa 12, wanda ya biyo baya fiye da matsakaicin watanni 15 a cikin gwajin asibiti na Pfizer / BioNTech. " Yawancin munanan abubuwan da aka ruwaito sun ƙunshi al'amuran gida (ciwo a wurin allura) ko bayyanar cututtuka na gaba ɗaya (gajiya, ciwon kai, sanyi, ciwon tsoka, zazzabi) kuma sun kasance gabaɗaya m zuwa matsakaici".

Alurar riga kafi ga masu shekaru 12-17: wane nau'i ne don yardar iyaye?

Tun da har yanzu ƙanana ne, ana iya yiwa matasa masu shekaru 12 zuwa 17 allurar rigakafi muddin suna da izinin iyaye daga iyaye ɗaya. Tun daga shekara 16, ana iya yi musu allurar ba tare da izinin iyayensu ba.

Lura cewa akwai ƴan lokuta da ba kasafai suke faruwa a Faransa waɗanda ƙanana za su iya ba samun magani ba tare da izinin daya ko duka biyun iyaye ba (maganin hana haihuwa da kuma musamman maganin safiya-bayan kwaya, ƙarewar ciki da son rai).

Menene dokar kan yardar iyaye ta ce game da alluran rigakafi?

Dangane da allurar rigakafin dole, 11 a adadi, yanayin ya bambanta.

A matakin shari'a, ana la'akari da cewa tare da cututtukan yara na yau da kullum da kuma kula da ƙananan raunuka. allurar rigakafin dole wani bangare ne na hanyoyin likita da aka saba, daga rayuwar yau da kullum. Suna adawa abubuwan da ba a saba gani ba (tsawon asibiti, maganin sa barci gabaɗaya, jiyya na dogon lokaci ko tare da sakamako masu yawa, da sauransu).

Don hanyoyin likita na yau da kullun, izinin ɗayan iyayen biyu ya isa, yayin Yarjejeniyar iyaye biyu ta zama dole don ayyukan da ba a saba ba. Don haka allurar rigakafin cutar ta Covid-19 zai shiga cikin wannan rukunin na aikin da ba a saba ba, tunda ba dole ba ne.

Covid-19: Shin allurar rigakafin yara masu shekaru 12-17 zai zama tilas?

A wannan matakin, amma ga tsofaffin Faransawa, rigakafin cutar Sars-CoV-2 ya kasance bisa son rai kuma ba zai zama tilas ba, in ji Ministan Haɗin kai da Lafiya.

Me yasa ake yiwa samari rigakafin alurar riga kafi tunda ba su da haɗarin kamuwa da nau'i mai tsanani?

Tabbas, matasa matasa suna cikin ƙananan haɗarin yin kwangilar manyan nau'ikan Covid-19. Koyaya, ta hanyar gurɓata, suna iya cutar da wasu, gami da mafi rauni (musamman kakanni).

Saboda haka, ra'ayin da ke tattare da allurar rigakafin matasa shine nacimma garkuwar jiki cikin sauri na yawan Faransanci, amma kuma naa farkon shekarar makaranta ta 2021, a guji rufe aji a makarantun tsakiya da sakandare. Domin ko da kamuwa da cuta ta Sars-CoV-2 sau da yawa yana da ɗan alamar alama a cikin matasa, yana haifar da ka'idar lafiya mai nauyi da ƙuntatawa a cikin makarantu.

Shin rigakafin zai kasance a buɗe ga yara a ƙarƙashin 12?

A wannan matakin, allurar rigakafin Sars-CoV-2 ba a buɗe wa yara a ƙarƙashin 12 ko wanene su. Idan wannan ba tukuna a kan ajanda, ba a cire cewa halin da ake ciki na iya samo asali a cikin ni'imar allurar rigakafin kasa da 12s, idan karatu a kan wannan batu ne m da kuma idan kiwon lafiya hukumomin hukunci m riba / hadarin rabo.